coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Coco PCN, Runnymede · Health Inequalities Profile

    PCN U20165 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,823

    Registered population

    61.0% aged 18–64

    18.0%

    Aged 65+

    ICB 18.8% · England 17.9%

    13.5%

    Ethnic minority (non-White)

    7.1% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    6,547

    Hypertension register

    +3.44% in 3 yrs · England +5.60%

    398

    SMI register

    54.7% of Runnymede's

    712

    COPD register

    Reviews -8.99% in 3 yrs

    Forecast to 2030

    7,871

    Hypertension patients, 2016

    +1,324 on today

    62.9%

    QRISK ≥20% on statins, 2016

    +0.15pp over 3 yrs

    5.0%

    Cancer prevalence, 2016

    England 4.5%

    Three things the board should see

    866
    Respiratory annual reviews lag behind local benchmarks.

    COPD reviews fell 9.0% over 2023 to 2025 (England +2.8%), and asthma reviews at 65.5% (Runnymede 71.0%) leave about 866 of 2,509 patients unreviewed.

    62.6%
    Older-adult blood pressure and statin uptake trail England.

    QRISK ≥ 20% lipid therapy reached 62.6% (+0.2% vs England +6.2%) while 80+ BP control fell 1.5% to 78.9%, alongside £29,387 higher lipid-modifying spend.

    +10.2%
    Non-frail diabetes and under-80 blood pressure control improved.

    Non-frail diabetes HbA1c control grew +10.2% to 59.1% (England 57.4%, +4.4%) and under-80 hypertension BP control rose +7.1% to 69.1% (England 67.8%, +3.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered list reaches 45,823 with 21.0% aged under 18 and 9.1% projected growth

    COCO PCN has 45,823 registered patients across member practices. Children aged 0–17 comprise 21.0% of the list (9,631 patients), above Runnymede (19.7%), NHS Surrey Heartlands ICB (20.4%), and England (19.6%). Adults aged 65+ represent 18.0% (8,237 patients; Runnymede 17.9%, ICB 18.8%, England 17.9%). Unverified projections indicate 9.1% list growth by 2030 (Runnymede 9.8%, ICB 4.9%, England 2.3%). Area Census residents show 86.5% White (Runnymede 83.5%, ICB 85.3%, England 81.1%) and 13.5% ethnic minority residents (Asian 7.1%), reflecting resident rather than registered ethnicity.

    Age profile

    0–1721.0%
    18–6461.0%
    65+18.0%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White86.5%
    Asian7.1%
    Mixed3.2%
    Black1.8%
    Other1.4%

    Older people · falls rows are Runnymede local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Runnymede LA)1,7712,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.5%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.1%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Runnymede LA)8299819552024/25
    Falls deaths, all ages, per 100,000 (Runnymede LA)11.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    The PCN records 0.0% Core20 share despite an average IMD decile of 6.7

    COCO PCN records a 0.0% Core20 share, below Runnymede (1.4%), NHS Surrey Heartlands Integrated Care Board (0.8%), and England (21.0%), giving 0 estimated Core20 residents. Its average IMD decile of 6.7 is below Runnymede (7.3) and the ICB (7.9), but above England (5.5). The PCN also holds 54.7% of Runnymede's severe mental illness register (398 patients) and 59.1% of its learning disability register (233 patients). Zero area-level deprivation may mask household need, suggesting outreach should focus on clinical registers rather than geographic deprivation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Chertsey0.0% · 0 patients
    Crouch Oak0.0% · 0 patients
    New Ottershaw0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    398

    SMI register

    0.88% recorded prevalence

    233

    Learning disability register

    0.51% recorded prevalence

    11

    Care homes, 514 beds

    In the PCN catchment

    8.2%

    Provide unpaid care

    Runnymede, Census 2021

    The PCN records 398 severe mental illness patients (0.9% vs England 1.0%) and 233 with learning disabilities (0.5% vs England 0.6%), representing 54.7% and 59.1% of Runnymede's caseloads, alongside 11 catchment care homes (514 beds). Runnymede records 8.2% unpaid care and 7 rough sleepers separately. Carrying over half the borough's inclusion-health caseload despite register prevalence below England makes protecting annual physical-health check capacity the operational priority.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 88.6% (+0.03 pp over three years vs England +4.4 pp) and BMI recording reached 88.9% (+0.6 pp vs +5.1 pp). While both exceed England (83.4% and 82.1%), three-year progress has slowed.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,547

    Hypertension register

    +3.44%

    Register growth, 3 yrs

    Runnymede +4.39% · England +5.60%

    +4.61pp

    BP control, under 80

    ≤140/90 · −1.23pp aged 80+

    +1,324

    More patients by 2030

    Forecast 7,871 (15.46%)

    Hypertension case-finding and control

    Hypertension prevalence is 14.4% (6,547 patients), in line with Runnymede (14.1%) and NHS Surrey Heartlands Integrated Care Board (14.3%), and below England (15.2%). Blood pressure control in patients aged under 80 reached 69.1%, rising +7.1% over three years (England +3.2%). Conversely, blood pressure control for patients aged 80 and over fell 1.5% over three years to 78.9%, trailing Runnymede (79.6%, +1.4%), the ICB (79.9%, +1.7%), and England (81.2%, +2.2%). Control for patients aged 80 and over was 72.5% at Crouch Oak Family Practice and 82.9% at Chertsey Health Centre. Declining blood pressure control in patients aged 80 and over indicates a need to review management protocols in older cohorts.

    Lipids and statins

    Lipid-lowering therapy for patients with QRISK ≥ 20% is 62.6%, exceeding Runnymede (61.8%) and the ICB (59.4%) but trailing England (63.6%). Over three years, treatment grew +0.2% locally against +6.2% nationally. Statin treatment uptake in high-risk patients lags national growth.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202654,421£2.40£2.24£1.86£130,610
    Cardiovascular (all), 202584,557£4.79£4.74£3.33£405,028

    For lipid-modifying drugs in 2026, the PCN prescribed 54,421 items at £2.40 per item, compared with £2.12 in Runnymede, £2.24 in the ICB, and £1.86 in England. The PCN spent £29,387 more than at England's unit cost across these items. Higher unit cost per item may reflect local formulary choices across prescribed agents.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.32%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.79%

    Asthma prevalence, PCN 3-yr % change

    COPD annual reviews fell 9.0% over three years to 77.2% (Runnymede 81.4%, England +2.8%), reaching 70.7% at Crouch Oak Family Practice and 85.2% at New Ottershaw Surgery. Asthma reviews reached 65.5% (falling 0.3% vs England +4.4%), trailing Runnymede (71.0%) and leaving an estimated 866 of 2,509 register patients unreviewed. COPD prevalence is 1.6% (712 patients). Declining review trends indicate delivery lags for diagnosed respiratory patients.

    Cancer register and children's immunisation

    Cancer prevalence is 4.1% (1,848 patients; England 3.8%). Childhood 6-in-1 coverage at 12 months reaches 96.0% (England 91.0%). By age 5, MMR dose 2 drops to 88.5%, trailing dose 1 (93.8%) by 5.3 pp, and 4-in-1 booster coverage falls to 85.4%, below the 95.0% target by 9.6 pp. Preschool booster drop-off leaves older children under-protected despite strong infant uptake.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.0%

    England 91.0%

    6-in-1 complete primary course at 24 months93.3%

    England 92.2%

    MMR dose 1 at 24 months92.3%

    England 88.3%

    MMR dose 2 at age 588.5%

    England 82.8%

    4-in-1 pre-school booster at age 585.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, 61.4% of cancers with a known stage in NHS Surrey Heartlands ICB were diagnosed at stage 1 or 2 (England 55.3%), 13.6 percentage points below the 75.0% national ambition. This gap represents approximately 652.5 additional early-stage cases across 4,810 staged cancers (67.7% known-stage coverage out of 7,106 registered cancers). Early detection was 88.2% in breast and 65.7% in prostate, but lower in bowel (48.1%) and lung (33.2%). Meanwhile, PCN breast screening coverage reached 66.0%, trailing England (69.9%) and the ICB (71.2%). Stage data reflects ICB system delivery rather than PCN performance, but lower screening uptake may constrain early identification.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Ashford and St Peter's Hospitals NHS Foundation Trust achieved 85.5% on the 28-day faster diagnosis standard (exceeding the 75.0% target), but reached 76.4% on the 62-day treatment standard, 8.6 percentage points below the 85.0% standard. Comparatively, Kingston and Richmond NHS Foundation Trust achieved 75.3% and Frimley Health NHS Foundation Trust 81.8%, against 71.5% across NHS Surrey and Sussex Integrated Care Board and 71.2% in England. Ashford and St Peter's diagnostic 6-week waits matched England at 23.1%, but endoscopy faced pressure, including colonoscopy at 49.6% and gastroscopy at 56.7%, which could delay gastrointestinal investigation pathways.

    Pathways within standard (%)Ashford and St Peter'sFrimley HealthKingston and RichmondSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)85.5387.9580.0779.2979.32
    31-day treatment (96%)94.2192.8998.7790.4592.50
    62-day referral to treatment (85%)76.3881.8475.3271.5171.16
    Diagnostic waits over 6 weeks (%)Ashford and St Peter'sFrimley HealthKingston and RichmondEngland
    MRI0.0912.850.1921.40
    CT9.270.630.009.92
    Echocardiography0.973.354.8928.48
    Colonoscopy49.6122.8470.1730.83
    Gastroscopy56.747.4379.1829.02
    All 15 DM01 tests23.127.4931.5623.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In June 2026, provisional community services data recorded 109,530 care contacts and 66,060 care activities for Surrey residents, with NHS Surrey and Sussex Integrated Care Board reporting 309,615 contacts overall. Adults aged 65 and over accounted for 69.6% of Surrey resident contacts (76,215 contacts). These experimental figures reflect broad upper-tier activity and submitting providers rather than distinct COCO PCN patient cohorts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access varies by 28.2 pp and QOF vaccination achievement spans 16.4 pp

    Overall QOF achievement reached 95.8% at Crouch Oak Family Practice, 95.3% at New Ottershaw Surgery, and 91.5% at Chertsey Health Centre (England 92.5%). Vaccination and immunisation achievement spanned a 16.4 pp range, from 46.7% at Chertsey Health Centre to 63.0% at Crouch Oak Family Practice (England 55.2%), indicating marked variation in preventive delivery across member practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    New Ottershaw1050.083.2%84.5%94.7%
    Crouch Oak1120.054.9%69.5%82.0%
    Chertsey920.063.6%70.5%78.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNRunnymedeAssetPCNRunnymede
    Care homes (catchment)11 (514 beds)n/aSchools (catchment)44n/a
    Children's centres35Places of worship1638
    Libraries36Homelessness support (VCS)0no data
    Day centres (VCS)11Carers support groups (VCS)n/a1
    Primary schools (LA maintained)610Primary academies67

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory annual review recall

    Asthma reviews reached 65.5% (Runnymede 71.0%, England 65.7%; -0.3% vs England +4.4% over three years), leaving 866 of 2,509 patients unreviewed; COPD reviews fell 9.0% to 77.2% across 712 patients (Runnymede 81.4%, England +2.8%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Older-adult hypertension and lipid review

    Across 6,547 hypertension patients (14.4%), 80+ BP control fell 1.5% to 78.9% (England 81.2%, +2.2%). QRISK >=20% lipid therapy grew +0.2% to 62.6% (England 63.6%, +6.2%); 54,421 lipid-modifying items cost £29,387 more than at England's £1.86 unit cost (£2.40). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Inclusion-health physical check recall

    The PCN holds 54.7% of Runnymede's SMI register (398 patients, 0.9%) and 59.1% of its learning disability register (233 patients, 0.5%; range -26 to +36 vs England 0.6%). SMI changes trailed England in BP (+0.03 pp vs +4.4 pp; 88.6%) and BMI (+0.6 pp vs +5.1 pp; 88.9%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Register-based inclusion health outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check review (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older adult hypertension review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster recall review (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted breast screening recall (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Telephony and triage access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN & Practice
    Option 2 · Older-adult hypertension and lipid review (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Inclusion-health physical check recall (p12)Severe mental illness register · Severe mental illness: QOF prevalence · Learning disability registerMHIS · From Harm to Hope · 75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15